SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-06 |
| Reported value | $157,257,160 |
| Positions | 23 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CAREDX INC | CDNA | COM | $15,586,451 | 546,893 |
| AMERESCO INC | AMRC | CLA | $13,049,225 | 472,798 |
| ENTERPRISE PRODS PARTNERS L P | EPD | COM | $12,493,879 | 339,877 |
| GENEDX HOLDINGS CORP | WGS | COM CL A | $12,210,776 | 177,870 |
| EQUINIX INC | EQIX | COM | $11,169,209 | 10,715 |
| HINGE HEALTH INC | HNGE | CL A | $9,404,232 | 113,304 |
| PACIRA BIOSCIENCES INC | PCRX | COM NEW | $8,946,401 | 352,637 |
| FRESHWORKS INC | FRSH | CLASS A COM | $7,855,265 | 776,212 |
| BIOLIFE SOLUTIONS INC | BLFS | COM NEW | $7,743,888 | 274,217 |
| FIVE9 INC | FIVN | COM | $7,169,426 | 336,277 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.